Government's revenue authority has recast the VAT-fixation and-payment modalities on medicines to merge dual taxation down, in a fiscal remedy meant for making lifesaving drugs cheaper. Prices of medicines have registered rise on many occasions, generating criticism of the drug-makers from different corners, including public-health campaigners and sufferers. Sources say the National Board of Revenue has amended the value-added tax (VAT) method following request of the pharmaceutical companies as they have to pay the tax at two stages to adds up to medicine prices. The pharmaceutical companies have to pay higher VAT than payable amount under the VAT law due to "faulty calculation method in the VAT law" since 2019, officials said. The VAT wing issued an order Tuesday with...